Ignite Creation Date:
2024-05-06 @ 5:57 PM
Last Modification Date:
2024-10-26 @ 2:39 PM
Study NCT ID:
NCT05493293
Status:
TERMINATED
Last Update Posted:
2024-04-12
First Post:
2022-08-05
Brief Title:
Extension Study to Evaluate the Safety and Tolerability of NBI-921352 When Used With Anti-seizure Medications in Adults With Focal Onset Seizures
Sponsor:
Neurocrine Biosciences
Organization:
Neurocrine Biosciences
Organization Data
Organization:
Neurocrine Biosciences
Class:
INDUSTRY
Study ID:
NBI-921352-FOS2022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Neurocrine Biosciences
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None